Greenway Health Expands into India with Seasoned Team at the Helm

Greenway Health Expands into India with Seasoned Team at the Helm

US-based health information technology services provider, Greenway Health has announced it has expanded its operations with a recently launched office in Bangalore, India. The expansion follows a period of innovation for Greenway, a Vista Equity Partners portfolio company, and signifies the company’s commitment to rapid product and software execution, revenue growth and client success. Throughout…

Novavax COVID-19 Vaccine Demonstrates

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection in PREVENT-19 Phase 3 Trial

Novavax Inc has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. The study enrolled 29,960 participants across 119 sites in the U.S. and Mexico to evaluate efficacy, safety and immunogenicity, with an emphasis on…

Industry Veteran Bhaskar Sambasivan Named President of CitiusTech

Industry Veteran Bhaskar Sambasivan Named President of CitiusTech

CitiusTech, a leading provider of healthcare technology services, products and solutions, has announced the appointment of Bhaskar Sambasivan as President. Sambasivan will focus on strengthening CitiusTech’s client relationships, building deeper healthcare capabilities & solutions, developing strategic offerings and driving business growth. Over the past 17 years, CitiusTech has established itself as a global leader in…

Doctors at BYL Nair Hospital Develop 5 New Homoeopathic Drugs

Doctors at BYL Nair Hospital Develop 5 New Homoeopathic Drugs Which Show Effects Against Fungus & Bacteria: Biosimilia Research

In breakthrough research by Indian homoeopath, Dr Rajesh Shah in collaboration with clinical pharmacologists at Mumbai’s BYL Nair Hospital, five new homoeopathic drugs have shown anti-fungal and anti-bacterial effects in a laboratory model. The research paper was published last week in a peer-reviewed; a Pub-med listed British Homeopathy Journal. In this research, five new homoeopathic nosodes were developed from…

Samsung Pharm & GemVax

Samsung Pharm & GemVax Present Pancreatic Cancer Immunotherapeutic Drug, RIAVAX Phase III Results at ASCO 2021

Samsung Pharm Co Ltd has announced that the company presented the results of phase III clinical trial of its pancreatic cancer immunotherapeutic drug candidate called ‘RIAVAX™ (GV1001)’ conducted in Korea at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will…

Bajaj Healthcare Launches Drug

Bajaj Healthcare Launches Drug for the Treatment of Mucormycosis Infection

Bajaj Healthcare has reportedly launched Posaconazole API which is used in the treatment of mucormycosis (black fungus) infection in COVID-19 patients. According to reports, a regulatory filing by Bajaj Healthcare states that the company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat, to manufacture and market Posaconazole API as approved medication…

Government of Haryana has partnered with Deloitte to launch Sanjeevani Pariyojana

Government of Haryana & Deloitte Launch ‘Sanjeevani Pariyojana’ for Quick Healthcare Access for Mild-Moderate COVID-19 Symptoms

The Government of Haryana has partnered with Deloitte to launch Sanjeevani Pariyojana (the ‘life project’), a supervised, virtual home-care initiative to help people quickly access healthcare for mild-to-moderate symptoms of COVID-19. Sanjeevani Pariyojana provides individuals with support and resources to manage their care at home including access to virtual triage, as well as COVID-19 field hospitals and…